BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28958584)

  • 1. Evaluation of 17-alpha hydroxyprogesterone caproate efficacy.
    Hauspurg A; Caritis SN; Venkataraman R
    Am J Obstet Gynecol; 2018 Feb; 218(2):261. PubMed ID: 28958584
    [No Abstract]   [Full Text] [Related]  

  • 2. Some biological activities of certain progestogens. I. 17 alpha-Hydroxyprogesterone 17-n-caproate.
    KESSLER WB; BORMAN A
    Ann N Y Acad Sci; 1958 Jul; 71(5):486-93. PubMed ID: 13583805
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction of marked as well as prolonged biologic activity by esterification; 17-alpha-hydroxyprogesterone caproate, a unique progestational compound.
    REIFENSTEIN EC
    Fertil Steril; 1957; 8(1):50-79. PubMed ID: 13405048
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to 17-alpha hydroxyprogesterone caproate.
    Frappaolo A; Vadnais M
    Am J Obstet Gynecol; 2018 Aug; 219(2):217. PubMed ID: 29698618
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on growth and fattening of cattle.
    GASSNER FX; REIFENSTEIN EC
    Ann N Y Acad Sci; 1958 Jul; 71(5):572-6. PubMed ID: 13583813
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of persistent acne in women with 17 alpha hydroxyprogesterone caproate (delalutin); a preliminary report.
    BAKER KC
    J Invest Dermatol; 1958 Nov; 31(5):247-50. PubMed ID: 13598928
    [No Abstract]   [Full Text] [Related]  

  • 7. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
    Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
    Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-acting progestin: 17-alpha-hydroxyprogesterone-N-caproate].
    ANSELMI F; DELLA BELLA D
    Boll Soc Ital Biol Sper; 1955; 31(11-12):1639-43. PubMed ID: 13329249
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on adrenal steroid excretion.
    CLARK SL; GREENBLATT RB
    Ann N Y Acad Sci; 1958 Jul; 71(5):710-6. PubMed ID: 13583826
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on the reproductive performance of cattle.
    JOHNSON KR
    Ann N Y Acad Sci; 1958 Jul; 71(5):577-9. PubMed ID: 13583814
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of 17-alpha-hydroxyprogesterone caproate to maintain pregnancy.
    MEYERHOFF KH; BROWN WH; CIOFFI LA
    Curr Ther Res Clin Exp; 1962 Oct; 4():499-505. PubMed ID: 13935332
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate.
    SHEARMAN RP; GARRETT WJ
    Br Med J; 1963 Feb; 1(5326):292-5. PubMed ID: 13977012
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical application of 17 alpha-hydroxyprogesterone 17-n-caproate.
    GOLD JJ; COHEN MR
    Ann N Y Acad Sci; 1958 Jul; 71(5):691-703. PubMed ID: 13583824
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in habitual abortion.
    REIFENSTEIN EC
    Ann N Y Acad Sci; 1958 Jul; 71(5):762-86. PubMed ID: 13583832
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological action of 17 alpha-hydroxyprogesterone 17-n-caproate on the reproductive processes of the rat.
    VELARDO JT
    Ann N Y Acad Sci; 1958 Jul; 71(5):542-54. PubMed ID: 13583810
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate.
    Berghella V; Owen J; Szychowski JM
    Obstet Gynecol; 2017 Feb; 129(2):390-391. PubMed ID: 28121824
    [No Abstract]   [Full Text] [Related]  

  • 17. Attempts to induce and maintain pregnancy in prepuberal mice following treatment with 17 alpha-hydroxyprogesterone 17-n-caproate.
    SMITHBERG M
    Ann N Y Acad Sci; 1958 Jul; 71(5):555-9. PubMed ID: 13583811
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of a new long-acting progestational steroid (17-alpha-hydroxyprogesterone caproate) in the therapy of secondary amenorrhea; a preliminary report.
    COHEN MR; DRESNER MH; FRANK R; GOLD JJ
    Am J Obstet Gynecol; 1956 Nov; 72(5):1103-15. PubMed ID: 13362422
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
    EICHNER E
    Ann N Y Acad Sci; 1958 Jul; 71(5):787-93. PubMed ID: 13583833
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins.
    Attardi BJ; Zeleznik A; Simhan H; Chiao JP; Mattison DR; Caritis SN;
    Am J Obstet Gynecol; 2007 Dec; 197(6):599.e1-7. PubMed ID: 18060946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.